Revvity (RVTY) | Stock Overview & Key Data
Revvity Performance Comparison
Stock Range
Today's Range
Low: $85.80
High: $88.35
on August 1, 2025
52 Week Range
Low: $85.80
High: $129.50
on August 1, 2025
on November 6, 2024
All-Time High: $203.16 on December 27, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$10.4B
EPS
2.30
P/E Ratio (TTM)
38.36
Forward P/E
17.10
P/B Ratio
1.37
PEG Ratio
17.10
Div. Yield
0.30%
ROE
3.61%
Beta
0.980
Debt to Equity
44.66
Financial Highlights
Profitability
Gross Margin
56.49%
Operating Margin
14.49%
Profit Margin
10.19%
Returns and Earnings
Return on Assets (TTM)
2.07%
Return on Equity (TTM)
3.61%
EBITDA
$842.1M
Net Income (TTM)
$278.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$23.20
Quarterly Revenue Growth (YoY)
4.10%
Quarterly Earnings Growth (YoY)
-2.60%
Dividend Information
Last 12-Month Dividend
$0.28
Current Dividend Yield
0.30%
3-Year Average Dividend Yield
0.06%
3-Year Average Annual Dividend
$0.28
3-Year Total Dividends
$0.84
Ex-Dividend Date
April 17, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Revvity RVTY | 10.40B Large-cap | -14.89% | -10.91% | -5.03% | -28.67% | -21.22% | -28.43% | -42.60% | -26.06% |
| Thermo Fisher TMO | 174.79B Large-cap | -3.19% | 9.86% | 10.28% | -22.01% | -11.39% | -24.79% | -21.55% | 11.76% |
| Danaher DHR | 141.13B Large-cap | -4.08% | -1.99% | 0.19% | -8.01% | -14.24% | -28.78% | -23.34% | 8.24% |
| Idexx Laboratories IDXX | 43.07B Large-cap | -5.25% | -1.31% | 13.61% | 14.18% | 30.99% | 14.28% | 31.33% | 40.28% |
| Agilent Technologies A | 32.24B Large-cap | -5.56% | -5.77% | 6.61% | -23.64% | -14.94% | -18.37% | -15.05% | 16.08% |
| Iqvia Holdings IQV | 31.02B Large-cap | -8.39% | 12.20% | 20.75% | -8.37% | -6.49% | -24.54% | -22.28% | 13.65% |
Ownership & Short Interest
Insider Ownership
0.35%
Institutional Ownership
98.77%
Shares Short
6M
Short Ratio
5.76
Short % of Shares Outstanding
7.34%
Average 10-Day Volume
2M
Average 90-Day Volume
1M
Revvity Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Revvity would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is RVTY's 52-week high and low?
- In the last 52 weeks, Revvity reached a high of $129.50 (on November 6, 2024) and a low of $85.80 (on August 1, 2025).
- What is the market cap and P/E ratio for RVTY?
- Curious about Revvity's size and valuation? Its market capitalization stands at 10.40B. When it comes to valuation, the P/E ratio (trailing twelve months) is 38.36, and the forward P/E (looking ahead) is 17.10.
- Does RVTY pay dividends? If so, what's the yield?
- Yes, Revvity is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.30%, and the company has paid an average of $0.28 per share annually over the past 3 years.
- Who are Revvity's main competitors or similar companies to consider before investing?
When looking at Revvity, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO174.79B Healthcare Diagnostics & Research -24.79% -21.55% Danaher
DHR141.13B Healthcare Diagnostics & Research -28.78% -23.34% Idexx Laboratories
IDXX43.07B Healthcare Diagnostics & Research 14.28% 31.33% Agilent Technologies
A32.24B Healthcare Diagnostics & Research -18.37% -15.05% Iqvia Holdings
IQV31.02B Healthcare Diagnostics & Research -24.54% -22.28% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Revvity Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Revvity's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.61%, the Debt to Equity ratio from the most recent quarter is 44.66, and its Gross Profit Margin stands at 56.49%.
- What is the recent revenue and earnings growth for RVTY?
- Looking at Revvity's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.10%, and quarterly earnings saw a YoY growth of -2.60%.
- How much of RVTY stock is held by insiders and institutions?
- Wondering who owns Revvity stock? Company insiders (like executives and directors) hold about 0.35% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 98.77%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.